Savara (SVRA) Competitor Comparison
We are evaluating the key criteria listed to compare Savara (SVRA) against its competitors in the Biotechnology industry.
Market Capitalization
151 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
139 / 337Free Cashflow
148 / 352Quick Ratio
29 / 357Earnings per Share
76 / 359Dividend yield
0 / 6Total Cash
175 / 358Performance 3 years
26 / 368Performance 5 years
53 / 368Performance 10 years
152 / 368Linearity 3 years
219 / 368Linearity 5 years
198 / 368Linearity 10 years
139 / 367Total Rank
257 / 368Dividend Rank
267 / 368Valuation Rank
228 / 368Piotroski Rank
159 / 368Muliplier Rank
201 / 368Market Capitalization - SVRA ranking 151 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.